The National Health Surveillance Agency (Anvisa) announced this Monday (11) that it will not renew the validity of the notices calling for medicines and medical oxygen. “Considering the current epidemiological scenario and the high administrative burden required of those involved to maintain these notices and data, the agency decided not to publish new notices at this time. It is important to highlight that, if the scenario changes and it is necessary to receive the information again, new public notices may be published”, the agency said in a note.
Anvisa recalled that it has acted in different ways in order to expand production and access to medicines and medical oxygen during the pandemic caused by the new coronavirus (covid-19).
In the same retrospect, Anvisa highlighted that, since 2020, several call notices have been published for drug registration holders to inform the agency of data on the manufacture, import and distribution of anesthetics, sedatives, neuromuscular blockers and adjuvant agents, among others. medicines, used to maintain the lives of patients infected by the virus.
Anvisa added that in the same way, since 2021, companies that manufacture, fill and distribute medical oxygen provide information on stock, sale and production. These measures were aimed at monitoring production and sales data of the drugs listed in the notices, vaccines against covid-19 and medical oxygen.
“The objective was to enable health managers to map the amount of such products available to serve the Brazilian population, as well as data regarding the location of stocks. Thus, the Ministry of Health and other health managers could have predictability, allowing the adoption, in a timely manner, of the necessary measures to guarantee the supply of these essential products. And Anvisa could understand the scenario and evaluate the possibility of granting exceptionalities and flexibilities, weighing the risk and benefit of these measures”, highlighted Anvisa.
